Skip to content

Effect of bariatric surgery dependent weight loss on gut barrier function and the inflammatory status

Effect of bariatric surgery dependent weight loss on gut barrier function and the inflammatory status

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00009008
Enrollment
60
Registered
2016-08-11
Start date
2015-03-13
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E66

Interventions

Group 1: 20-30 obese patients (BMI = 40 kg/m2) undergoing laparoscopic sleeve gastrectomy are included in the study. Before and six months after surgery the intestinal permeability is investigated by

Sponsors

Else Kröner-Fresenius Zentrum für Ernährungsmedizn, Lehrstuhl für Ernährungsmedizin, Technische Universität München
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: written informed consent, BMI = 40 kg/m² for the bariatric surgery group, BMI < 30 kg/m² for the control group

Exclusion criteria

Exclusion criteria: absent written informed consent, poor complicance, serious illness, e.g. cancer, COPD, serious hart disease (e.g. pacemaker), serious mental illness, liver illness (AST, ALT > 3fold of normal value), renal disease (creatinine > 1.2 mg/dl), serious gastrointestinal, neurological, rheumatic illness, celiac disease, acute infections, hypokalemia, insulin-dependent diabetes mellitus, regular intake of antibiotics, immunesuppressants, laxatives, anti-diarrhea medication, malabsorption syndrome, autonomic neuropathy, lactulose intolerance, sucralose intolerance, sucrose intolerance

Design outcomes

Primary

MeasureTime frame
intestinal permeability: sugar resorption test; change in microbial composition of the colon: faecal sample, metagenomic sequencing of faecal microbiota; inflammatory parameters in blood: blood samples, CRP; marker of intestinal permeability in blood: blood samples, zonulin and LPS-binding protein; all parameters are measured before as well as six months after sugery in the obese patients and once in the control patients

Secondary

MeasureTime frame
anthropometry: body weight as well as waist-to-hip ratio; eating habits: 7 day dietary protocol; fasting insulin, fasting glucose, HbA1c: blood samples, laboratory analysis all parameters are measured before as well as six months after sugery in the obese patients and once in the control patients

Countries

Germany

Contacts

Public ContactTeresa Kellerer

Lehrstuhl für Ernährungsmedizin, Technische Universität München

teresa.kellerer@tum.de+49-(0)8161-71-2011

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 2, 2026